Drug research

Tafenoquine Oral Tablet

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as ARAKODA™; KODATEF™

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Tafenoquine in Patients With Mild to Moderate COVID-19NCT04533347	60 Degrees Pharmaceuticals LLC	Phase 2	Completed	2022-06-30Actual

60 Degrees Pharmaceuticals LLCCompletedPrimary completion: 2022-06-30 · Actual

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.